Aurora Cannabis Inc. buys Safari Flower Co. in $26.5M deal
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.99/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19.95 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
EDMONTON – Aurora Cannabis Inc. has bought Safari Flower Co. in a stock-and-cash deal valued at $26.5 million.
The acquisition includes a $2-million cash payment that is contingent on satisfaction of certain conditions.
Aurora says Safari Flower has an EU GMP certified indoor cultivation and manufacturing facility in Ontario.
It says the deal that will increase its capacity to supply key international markets, including Germany, Australia, Poland, and the United Kingdom, and support further market expansion.
Aurora executive chair and chief executive Miguel Martin says the acquisition of Safari Flower marks an important milestone as the company looks to grow its international medical cannabis business.
Martin says an enhanced supply chain will enable it to capture greater international market share while delivering superior quality and value to patients.
This report by The Canadian Press was first published April 15, 2026.
Companies in this story: (TSX:ACB)